Quest PharmaTech Inc (QPT) - Total Liabilities

Latest as of October 2025: CA$1.25 Million CAD ≈ $907.03K USD

Based on the latest financial reports, Quest PharmaTech Inc (QPT) has total liabilities worth CA$1.25 Million CAD (≈ $907.03K USD) as of October 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

Quest PharmaTech Inc - Total Liabilities Trend (1998–2025)

This chart illustrates how Quest PharmaTech Inc's total liabilities have evolved over time, based on quarterly financial data. See QPT working capital efficiency to evaluate short-term liquidity relative to the company's equity base.

Quest PharmaTech Inc Competitors by Total Liabilities

The table below lists competitors of Quest PharmaTech Inc ranked by their total liabilities.

Company	Country	Total Liabilities
Collplant Biotechnologies Ltd NASDAQ:CLGN	USA	$4.78 Million
Gungnir Resources Inc V:GUG	Canada	CA$29.60K
Traka Resources Ltd AU:TKL	Australia	AU$184.14K
METALQUEST MINING INC. F:E7Q	Germany	€358.31K
Tissue Repair Ltd AU:TRP	Australia	AU$607.50K
Sentral Mitra Informatika Tbk PT JK:LUCK	Indonesia	Rp22.81 Billion
Pure Foods Tasmania Ltd AU:PFT	Australia	AU$8.26 Million
Brüder Mannesmann Aktiengesellschaft F:BMM	Germany	€49.16 Million

Liability Composition Analysis (1998–2025)

This chart breaks down Quest PharmaTech Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Quest PharmaTech Inc market capitalisation.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	0.07	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.05	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.05	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Quest PharmaTech Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Quest PharmaTech Inc (1998–2025)

The table below shows the annual total liabilities of Quest PharmaTech Inc from 1998 to 2025.

Year	Total Liabilities	Change
2025-01-31	CA$1.17 Million ≈ $845.16K	-11.67%
2024-01-31	CA$1.32 Million ≈ $956.88K	+19.56%
2023-01-31	CA$1.11 Million ≈ $800.36K	+77.71%
2022-01-31	CA$622.60K ≈ $450.38K	+59.87%
2021-01-31	CA$389.44K ≈ $281.72K	-98.14%
2020-01-31	CA$20.95 Million ≈ $15.15 Million	+106.50%
2019-01-31	CA$10.14 Million ≈ $7.34 Million	+1.95%
2018-01-31	CA$9.95 Million ≈ $7.20 Million	+1256.57%
2017-01-31	CA$733.49K ≈ $530.60K	-94.49%
2016-01-31	CA$13.30 Million ≈ $9.62 Million	+227.17%
2015-01-31	CA$4.07 Million ≈ $2.94 Million	+22.68%
2014-01-31	CA$3.31 Million ≈ $2.40 Million	+95445.89%
1998-01-31	CA$3.47K ≈ $2.51K	--

About Quest PharmaTech Inc

V:QPT Canada Biotechnology

Market Cap

$4.28 Million

CA$5.92 Million CAD

Market Cap Rank

#28865 Global

#1324 in Canada

Share Price

CA$0.04

Change (1 day)

+0.00%

52-Week Range

CA$0.03 - CA$0.05

All Time High

CA$0.25